Tag: neurooncology
-
The Role Of Artificial Biomarkers In The Diagnosis And Treatment Of Neurological Tumours
The emergence of Artificial Intelligence (AI) has had a mass transformative effect in shifting healthcare to a positive enlightenment, particularly in neuro-oncology, where it empowered healthcare professionals to diagnose patient cases more efficiently, strengthen prognosis, and enable real-time monitoring and treatment planning (Khalighi et al., 2024). This helped improve the overall clinical outcomes of cancer…
-
A Novel Genetic Test Using Nanopore-based assay
Nanopore genetic sequencing is an innovative technique where the graphical interface software Rapid nanpOre Brain IntraoperatIve classificatioN (ROBIN) presents sequencing results of patients in real-time as data is being analysed and interpreted from a single assay (Deacon et al., 2025). The World Health Organisation (WHO) classification of tumours of the central nervous system (CNS) has…
-
New Advances In Neurological Cancer Treatment
Article One Vorasedenib: Accept Or Reject? ArticleTwo Advances in CAR T Cell Therapy Article Three A Genetic Test Using a Nanopore-based assay Article Four Cancer Research UK Clinical Trials Article Five The Role Of Artificial Biomarkers In The Diagnosis And Treatment Of Neurological Tumours
-
Vorasidenib: Accept Or Reject?
In recent reports, it was announced that the National Institute for Health and Care Excellence (NICE) has declined to formalize the acceptance of the use of Vorasidenib on the National Health Service (NHS). Vorasidenib is a targeted therapy that is administered orally for patients with low-grade gliomas. This took place in October 2025 on the…
The Farah Saeed Project 